The Value Signal — September 17, 2026

712 articles scanned · 15 high-signal

Signal Map

Executive Summary

Washington is trying to industrialize value-based care while the Medicare Advantage machine faces a credibility squeeze from audits, denials, and AI-enabled utilization management.

CMMI and ACO strategy is shifting from isolated demonstrations toward cross-payer infrastructure: Fierce Healthcare reports CMS is expanding the ACCESS model to more chronic conditions as officials pursue broader alignment, while Modern Healthcare reports Aledade is navigating both AI adoption and the ACCESS model as scaled primary care ACOs position themselves for the next policy cycle. Primary care execution risk remains high, with Medical Economics reporting concern that ACCESS could either create productive new partnerships or worsen fragmentation depending on how Medicare aligns incentives and workflows.

Prior authorization and Medicare Advantage oversight are becoming the pressure points for VBC legitimacy: STAT News reports Medicare’s AI prior authorization pilot was rushed and riddled with problems, while American Hospital Association reports it is surveying readiness for electronic prior authorization standards through Oct. 9. Becker's Payer reports Humana received $130.9 million in Medicare Advantage overpayments, and MedCity News reports rising MA denial rates are pushing some hospitals to bet more heavily on traditional Medicare—evidence that payer-side “value” claims are being tested against operational behavior and audit exposure.